MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 535020 | Name: Carindacillin

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Carindacillin is an acid stable indanyl ester of carbenicillin for oral use; same side-effects as carbenicillin.

Chemical Structure

Carindacillin
Carindacillin
CAS#35531-88-5

Theoretical Analysis

MedKoo Cat#: 535020

Name: Carindacillin

CAS#: 35531-88-5

Chemical Formula: C26H26N2O6S

Exact Mass: 494.1512

Molecular Weight: 494.56

Elemental Analysis: C, 63.14; H, 5.30; N, 5.66; O, 19.41; S, 6.48

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Carindacillin
IUPAC/Chemical Name
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((3-((2,3-dihydro-1H-inden-5-yl)oxy)-1,3-dioxo-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2-alpha,5-alpha,6-beta))-
InChi Key
JIRBAUWICKGBFE-MNRDOXJOSA-N
InChi Code
InChI=1S/C26H26N2O6S/c1-26(2)20(24(31)32)28-22(30)19(23(28)35-26)27-21(29)18(15-7-4-3-5-8-15)25(33)34-17-12-11-14-9-6-10-16(14)13-17/h3-5,7-8,11-13,18-20,23H,6,9-10H2,1-2H3,(H,27,29)(H,31,32)/t18?,19-,20+,23-/m1/s1
SMILES Code
O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(C(C3=CC=CC=C3)C(OC4=CC5=C(CCC5)C=C4)=O)=O)N1C2=O)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 494.56 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Modr Z, Dvovácek K, Janků I, Krebs V. Pharmacokinetics of carfecillin and carindacillin. Int J Clin Pharmacol Biopharm. 1977 Feb;15(2):81-3. doi: 10.103/00006450-11000-00004. PMID: 577917. 2: Li YH, Ito K, Tsuda Y, Kohda R, Yamada H, Itoh T. Mechanism of intestinal absorption of an orally active beta-lactam prodrug: uptake and transport of carindacillin in Caco-2 cells. J Pharmacol Exp Ther. 1999 Sep;290(3):958-64. PMID: 10454465. 3: Li YH, Tanno M, Itoh T, Yamada H. Role of the monocarboxylic acid transport system in the intestinal absorption of an orally active beta-lactam prodrug: carindacillin as a model. Int J Pharm. 1999 Nov 30;191(2):151-9. doi: 10.1016/s0378-5173(99)00299-9. PMID: 10564841. 4: Michiels HG, Debruyne FM, Moonen WA. The treatment of chronic pyelonephritis with carindacillin. Curr Med Res Opin. 1978;5(5):394-400. doi: 10.1185/03007997809111904. PMID: 350490. 5: Büscher HW, Schwartz L. Behandlung urologischer Infektionen mit Carindacillin [Treatment of urologic infections with Carindacillin]. Fortschr Med. 1976 Oct 21;94(30):1742-4. German. PMID: 791782. 6: Oosterlinck W, Desmet R. Treatment of pseudomonas urinary tract infections with carindacillin. Acta Urol Belg. 1975 Jul;43(3):330-4. PMID: 125533. 7: Percoco M, Antonelli D, Rabuffi F, Toti F. Valutazione dell'efficacia terapeutica e della tollerabilità dell'indanil-carbenicillina (carindacillina sodica) nelle infezioni urinarie in chirurgia [Evaluation of the therapeutic effectiveness and tolerability of indanyl carbenicillin (sodium carindacillin) in urinary infections in surgery]. Clin Ter. 1981 May 15;97(3):247-51. Italian. PMID: 6456864. 8: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. Carbenicillin Indanyl Disodium. 2018 Oct 31. PMID: 30000317. 9: Pogglitsch H. Carindacillin in der Behandlung von Harnwegsinfektionen [Carindacillin in the treatment of urinary tract infections]. Wien Med Wochenschr. 1976 Jun 11;126(24):357-9. German. PMID: 947104. 10: Naumann P, Rosin H. Zur oralen Carbenicillin-Therapie mit Carindacillin [Oral carbenicillin treatment with carindacillin (author's transl)]. Dtsch Med Wochenschr. 1973 Nov 16;98(46):2200-2 contd. German. doi: 10.1055/s-0028-1107223. PMID: 4202153. 11: Weiss W. Klinische Untersuchungen mit Carindacillin bei Harnweginfekten [Clinical studies on carindacillin in urinary tract infections]. Ther Ggw. 1975 Feb;114(2):226, 231-3, 236. German. PMID: 1091013. 12: Kruckenhauser EM, Nogler M, Coraça-Huber D. Use of lavage fluids in arthroplasty to prevent postoperative infections. Drug Res (Stuttg). 2014 Mar;64(3):166-8. doi: 10.1055/s-0033-1354367. Epub 2013 Aug 28. PMID: 23986306. 13: Hanus PM, Danziger LH. Treatment of chronic bacterial prostatitis. Clin Pharm. 1984 Jan-Feb;3(1):49-55. PMID: 6365416. 14: Popa G, Nuri M, Peters HJ. Behandlung von Harnweginfektionen mit Problemkeimen mit Indanyl-Carbenicillin [Indanyl Carbenicillin in the treatment of urinary tract infections due to difficult urological organisms (author's transl)]. Med Klin. 1976 Jan 16;71(3):104-9. German. PMID: 765706. 15: Seneca H. Relative efficacy of carbenicillin indanyl sodium and of trimethoprim/sulfamethoxazole in urinary-tract infections. J Am Geriatr Soc. 1979 May;27(5):222-4. doi: 10.1111/j.1532-5415.1979.tb06036.x. PMID: 581878. 16: Tsuji A, Miyamoto E, Kagami I, Sakaguchi H, Yamana T. GI absorption of beta- lactam antibiotics I: kinetic assessment of competing absorption and degradation in GI tract. J Pharm Sci. 1978 Dec;67(12):1701-4. doi: 10.1002/jps.2600671218. PMID: 581499. 17: Tsuji A, Miyamoto E, Terasaki T, Yamana T. Carbenicillin prodrugs: stability kinetics of alpha-phenyl and alpha-indanyl esters in aqueous solution. J Pharm Sci. 1979 Oct;68(10):1259-63. doi: 10.1002/jps.2600681017. PMID: 583161. 18: Choo CY, Hirasawa Y, Karimata C, Koyama K, Sekiguchi M, Kobayashi J, Morita H. Carinatumins A-C, new alkaloids from Lycopodium carinatum inhibiting acetylcholinesterase. Bioorg Med Chem. 2007 Feb 15;15(4):1703-7. doi: 10.1016/j.bmc.2006.12.005. Epub 2006 Dec 15. PMID: 17188496. 19: Nielsen OS, Frimodt-Moeller N, Maigaard S, Hoyme U, Baumueller A, Madsen PO. Penicillanic acid derivatives in the canine prostate. Prostate. 1980;1(1):79-85. doi: 10.1002/pros.2990010111. PMID: 6269107. 20: Rajan VS, Sng JE. Carbenicillin indanyl sodium in the treatment of gonorrhoea. Singapore Med J. 1974 Mar;15(1):37-9. PMID: 4841541.